Survodutide (6mg)
$225.00
Survodutide is a next-generation peptide that combines GLP-1 and glucagon receptor agonist activity, designed to deliver superior outcomes in fat loss, appetite control, and metabolic regulation.
-
Promotes Significant Weight Loss by reducing appetite and increasing energy expenditure.
-
Improves Metabolic Markers, including blood glucose, insulin sensitivity, and lipid profiles.
-
Targets Visceral & Liver Fat, supporting leaner body composition and reduced inflammation.
-
Once-Weekly Dosing offers long-lasting effects with excellent patient compliance.
Ideal for individuals seeking advanced, science-backed support for obesity, metabolic syndrome, or non-alcoholic fatty liver disease (NAFLD).
⚠️ For Research Use Only (RUO). Not for human consumption, diagnostic, or therapeutic use.
This product requires a medical consult before purchase. Please contact us for approval.
